Supplemental Annuity Collective Trust Of Nj Theravance Biopharma, Inc. Transaction History

Supplemental Annuity Collective Trust Of Nj

$316 Million
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 03, 2020	SELL	$20.64 - $30.69 $185,760 - $276,210	-9,000 Closed	0 $0
Q4 2019 Jan 31, 2020	BUY	$16.12 - $25.89 $145,080 - $233,010	9,000 New	9,000 $233,000

Others Institutions Holding TBPH

# of Institutions

124

Shares Held

49.6M

Call Options Held

1.4K

Put Options Held

2.3K

Weiss Asset Management LP Boston, MA

7.46M
Shares

$63.5 Million
2.91% of portfolio
Madison Avenue Partners, LP New York, NY

7.01M
Shares

$59.7 Million
12.55% of portfolio
Seth Klarman Baupost Group LLC | Boston, Ma

6.59M
Shares

$56.1 Million
1.62% of portfolio
Black Rock Inc. New York, NY

4.21M
Shares

$35.8 Million
0.0% of portfolio
Irenic Capital Management LP New York, NY

2.76M
Shares

$23.5 Million
5.05% of portfolio

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $568M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Supplemental Annuity Collective Trust Of Nj, based on Form 13F filings with the SEC.

News

Stay updated on Supplemental Annuity Collective Trust Of Nj with notifications on news.

Account